Since the publication of their paper, the authors have identified an error in the 5-year overall survival rates for the four risk groups, which were listed incorrectly in the abstract, in the second paragraph of the Results section and in Table 4 . The correct 5-year OS rates are 95, 64, 46 and 22%, respectively. A revised version of Table 4 is reproduced below.
Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia M Metzler, MS Staege, L Harder, D Mendelova, J Zuna, E Fronkova, C Meyer, T Flohr, D Bednarova, J Harbott, T Langer, S Gesk, J Trka, R Siebert, T Dingermann, R Marschalek, C Niemeyer and W Rascher Leukemia (2008 Leukemia ( ) 22, 1812 doi:10.1038 /leu.2008 Correction to: Leukemia (2008 Leukemia ( ) 22, 1807 Leukemia ( -1811 doi:10.1038 /leu.2008 published online 13 March 2008 Since the publication of the above paper, the authors have detected a minor error that has no impact on the conclusion.
Please note that the second sentence of the third paragraph 'Flowcytometric analysis of the primary ALL showed common ALL phenotype with aberrant expression of CD66c, the myeloid marker CD13 and the progenitor marker CD117.' should be corrected to 'Flowcytometric analysis of the primary ALL showed common ALL phenotype with aberrant expression of CD66c and hyperdiploid DNA content (DNA index 1.17). ' The authors apologize for any inconvenience caused. 
